about
Targeted delivery of nanoparticles to ischemic muscle for imaging and therapeutic angiogenesis.Development of pro-angiogenic engineered transcription factors for the treatment of cardiovascular disease.VEGF-loaded graphene oxide as theranostics for multi-modality imaging-monitored targeting therapeutic angiogenesis of ischemic muscle.Utility of vascular endothelial specific peptides for enhancement of adeno-associated virus-mediated gene transfer.p53 gene therapy modulates signal transduction in the apoptotic and cell cycle pathways downregulating neointimal hyperplasia.
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Gene therapy for cardiovascular angiogenesis.
@ast
Gene therapy for cardiovascular angiogenesis.
@en
type
label
Gene therapy for cardiovascular angiogenesis.
@ast
Gene therapy for cardiovascular angiogenesis.
@en
prefLabel
Gene therapy for cardiovascular angiogenesis.
@ast
Gene therapy for cardiovascular angiogenesis.
@en
P2860
P356
P1476
Gene therapy for cardiovascular angiogenesis.
@en
P2093
Douglas W Losordo
Larry J Diaz-Sandoval
P2860
P304
P356
10.1517/14712598.3.4.599
P407
P577
2003-07-01T00:00:00Z